DE4206932A1 - Immunologische methode zur bestimmung eines haemoglobinderivates - Google Patents

Immunologische methode zur bestimmung eines haemoglobinderivates

Info

Publication number
DE4206932A1
DE4206932A1 DE4206932A DE4206932A DE4206932A1 DE 4206932 A1 DE4206932 A1 DE 4206932A1 DE 4206932 A DE4206932 A DE 4206932A DE 4206932 A DE4206932 A DE 4206932A DE 4206932 A1 DE4206932 A1 DE 4206932A1
Authority
DE
Germany
Prior art keywords
hemoglobin
content
derivative
sample
hemolysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4206932A
Other languages
German (de)
English (en)
Inventor
Johann Dipl Chem Dr Karl
Lorenz Dipl Chem Dr Kerscher
Erich Dipl Chem Dr Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE4206932A priority Critical patent/DE4206932A1/de
Priority to CZ93291A priority patent/CZ29193A3/cs
Priority to IL104902A priority patent/IL104902A0/xx
Priority to AU33871/93A priority patent/AU652092B2/en
Priority to SK14993A priority patent/SK14993A3/sk
Priority to PL29791593A priority patent/PL297915A1/xx
Priority to DE59310046T priority patent/DE59310046D1/de
Priority to EP93103349A priority patent/EP0559164B1/de
Priority to DK93103349T priority patent/DK0559164T3/da
Priority to AT93103349T priority patent/ATE193378T1/de
Priority to PT93103349T priority patent/PT559164E/pt
Priority to HR930253A priority patent/HRP930253A2/hr
Priority to NZ247054A priority patent/NZ247054A/en
Priority to NO93930770A priority patent/NO930770L/no
Priority to ES93103349T priority patent/ES2148190T3/es
Priority to US08/026,464 priority patent/US5541117A/en
Priority to FI930975A priority patent/FI930975A7/fi
Priority to CA002090981A priority patent/CA2090981C/en
Priority to ZA931533A priority patent/ZA931533B/xx
Priority to CN93104037A priority patent/CN1081765A/zh
Priority to HU9300596A priority patent/HUT70463A/hu
Priority to SI9300108A priority patent/SI9300108A/sl
Priority to JP5045130A priority patent/JP2637677B2/ja
Priority to KR1019930003336A priority patent/KR930020162A/ko
Publication of DE4206932A1 publication Critical patent/DE4206932A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE4206932A 1992-03-05 1992-03-05 Immunologische methode zur bestimmung eines haemoglobinderivates Withdrawn DE4206932A1 (de)

Priority Applications (24)

Application Number Priority Date Filing Date Title
DE4206932A DE4206932A1 (de) 1992-03-05 1992-03-05 Immunologische methode zur bestimmung eines haemoglobinderivates
CZ93291A CZ29193A3 (en) 1992-03-05 1993-02-26 Immunoassay for hemoglobin derivative determination
IL104902A IL104902A0 (en) 1992-03-05 1993-03-01 Immunological method for the determination of haemoglobin derivatives
AU33871/93A AU652092B2 (en) 1992-03-05 1993-03-01 Immunological method for the determination of a haemoglobin derivative
SK14993A SK14993A3 (en) 1992-03-05 1993-03-01 Immunological method to determine hbaic
PL29791593A PL297915A1 (en) 1992-03-05 1993-03-02 Method of immunologically detwermining a derivative of heamoglobin
DE59310046T DE59310046D1 (de) 1992-03-05 1993-03-03 Immunologische Methode zur Bestimmung von HbAIc
EP93103349A EP0559164B1 (de) 1992-03-05 1993-03-03 Immunologische Methode zur Bestimmung von HbAIc
DK93103349T DK0559164T3 (da) 1992-03-05 1993-03-03 Immunologisk fremgangsmåde til bestemmelse af HbA1c
AT93103349T ATE193378T1 (de) 1992-03-05 1993-03-03 Immunologische methode zur bestimmung von hbaic
PT93103349T PT559164E (pt) 1992-03-05 1993-03-03 Metodo imunologico para a determinacao de hbalc
HR930253A HRP930253A2 (en) 1992-03-05 1993-03-03 IMMUNOLOGICAL METHOD TO DETERMINE HbAIc
NZ247054A NZ247054A (en) 1992-03-05 1993-03-03 Immunological determination of haemoglobin derivative in a blood sample including test kits and haemolysis reagents for use in such method.
NO93930770A NO930770L (no) 1992-03-05 1993-03-03 Immunologisk fremgangsmaate for bestemmelse av et hemoglobinderivat
ES93103349T ES2148190T3 (es) 1992-03-05 1993-03-03 Metodo inmunologico para la determinacion de hba1c.
US08/026,464 US5541117A (en) 1992-03-05 1993-03-04 Immunological method for the determination of a haemoglobin derivative
FI930975A FI930975A7 (fi) 1992-03-05 1993-03-04 Immunologinen menetelmä hemoglobiinijohdannaisen määritykseen
CA002090981A CA2090981C (en) 1992-03-05 1993-03-04 Immunological method for the determination of a haemoglobin derivative
ZA931533A ZA931533B (en) 1992-03-05 1993-03-04 Immunological method for the determination of a haemoglobin derivative
CN93104037A CN1081765A (zh) 1992-03-05 1993-03-04 用于测定血红蛋白衍生物的免疫方法
HU9300596A HUT70463A (en) 1992-03-05 1993-03-04 Immunological method for determination of hemoglobin-derivate
SI9300108A SI9300108A (en) 1992-03-05 1993-03-05 Immunological method for the determination of hemoglobin derivatives
JP5045130A JP2637677B2 (ja) 1992-03-05 1993-03-05 ヘモグロビン誘導体の測定のための免疫学的方法
KR1019930003336A KR930020162A (ko) 1992-03-05 1993-03-05 헤모글로빈 유도체의 면역학적 측정방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4206932A DE4206932A1 (de) 1992-03-05 1992-03-05 Immunologische methode zur bestimmung eines haemoglobinderivates

Publications (1)

Publication Number Publication Date
DE4206932A1 true DE4206932A1 (de) 1993-09-09

Family

ID=6453281

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4206932A Withdrawn DE4206932A1 (de) 1992-03-05 1992-03-05 Immunologische methode zur bestimmung eines haemoglobinderivates
DE59310046T Expired - Lifetime DE59310046D1 (de) 1992-03-05 1993-03-03 Immunologische Methode zur Bestimmung von HbAIc

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59310046T Expired - Lifetime DE59310046D1 (de) 1992-03-05 1993-03-03 Immunologische Methode zur Bestimmung von HbAIc

Country Status (23)

Country Link
US (1) US5541117A (enExample)
EP (1) EP0559164B1 (enExample)
JP (1) JP2637677B2 (enExample)
KR (1) KR930020162A (enExample)
CN (1) CN1081765A (enExample)
AT (1) ATE193378T1 (enExample)
AU (1) AU652092B2 (enExample)
CA (1) CA2090981C (enExample)
CZ (1) CZ29193A3 (enExample)
DE (2) DE4206932A1 (enExample)
DK (1) DK0559164T3 (enExample)
ES (1) ES2148190T3 (enExample)
FI (1) FI930975A7 (enExample)
HR (1) HRP930253A2 (enExample)
HU (1) HUT70463A (enExample)
IL (1) IL104902A0 (enExample)
NO (1) NO930770L (enExample)
NZ (1) NZ247054A (enExample)
PL (1) PL297915A1 (enExample)
PT (1) PT559164E (enExample)
SI (1) SI9300108A (enExample)
SK (1) SK14993A3 (enExample)
ZA (1) ZA931533B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0708337A3 (en) * 1994-10-19 1996-06-12 Fuji Photo Film Co Ltd Analytical element and analysis method for glycolysed hemoglobin
EP0779513A1 (en) 1995-12-14 1997-06-18 Fuji Photo Film Co., Ltd. Method for immunological determination of hemoglobin derivative and treating reagent for use therein

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739037A (en) * 1992-09-29 1998-04-14 Drew Scientific Limited Process for eliminating labile glycohaemoglobin from a sample
US5610076A (en) * 1994-04-29 1997-03-11 Alteon Inc. Method for detecting hemoglobin advanced glycosylation endproducts
FR2721112B1 (fr) * 1994-06-13 1996-08-14 Gks Technologies Dispositif de diagnostic rapide de toute molécule glyquée et procédé de mise en Óoeuvre.
EP0729031A1 (en) * 1995-02-24 1996-08-28 F. Hoffmann-La Roche Ag Set of reagents determining the content of total haemoglobin
JP3551678B2 (ja) * 1996-03-14 2004-08-11 東ソー株式会社 ヘモグロビンＡ１ｃの測定法及びキット
US6855562B1 (en) * 1996-07-30 2005-02-15 Horiba, Ltd. Immunoassay method for lyzed whole blood
JP3249919B2 (ja) * 1996-07-30 2002-01-28 株式会社堀場製作所 免疫測定方法
US5858794A (en) * 1997-05-13 1999-01-12 Bayer Corporation Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers
DE69819996T2 (de) * 1997-09-27 2004-09-02 Horiba Ltd. Gerät für die Zählung von Blutzellen und zur immunologischen Bestimmung unter Verwendung von Vollblut
US6485923B1 (en) 2000-02-02 2002-11-26 Lifescan, Inc. Reagent test strip for analyte determination having hemolyzing agent
WO2002021142A1 (en) * 2000-09-07 2002-03-14 Wako Pure Chemical Industries, Ltd. Method of quantifying total hemoglobin and glycohemoglobin
GB0110053D0 (en) * 2001-04-24 2001-06-13 Axis Shield Asa Assay
AU2003291250A1 (en) * 2002-11-05 2004-06-07 Therasense, Inc. Assay device, system and method
CA2527199C (en) * 2003-05-27 2011-11-22 Mitsubishi Kagaku Iatron, Inc. Immunochromatographic method
US7659107B2 (en) * 2003-09-23 2010-02-09 Epinex Diagnostics, Inc. Rapid test for glycated albumin
BRPI0415886A (pt) * 2003-10-29 2007-01-09 Mec Dynamics Corp tiras descartáveis e método de determinação da porcentagem de hbalc na hemoglobina
US7150995B2 (en) 2004-01-16 2006-12-19 Metrika, Inc. Methods and systems for point of care bodily fluid analysis
US7541190B2 (en) * 2005-02-07 2009-06-02 Beckman Coulter, Inc. Method of measurement of cellular hemoglobin
US8921052B2 (en) * 2005-04-14 2014-12-30 Panasonic Healthcare Co., Ltd. Hemoglobin derivative measurement method, and reagent composition, measurement kit, analysis device and analysis system for use in the method
JP4989628B2 (ja) * 2006-03-24 2012-08-01 アークレイ株式会社 グリコヘモグロビン濃度測定方法および濃度測定装置
US8268625B2 (en) * 2006-03-24 2012-09-18 Arkray, Inc. Method of measuring glycated hemoglobin concentration and concentration measuring apparatus
US20100012049A1 (en) * 2006-04-12 2010-01-21 Jms Co., Ltd Cavitation heating system and method
EP2047272B1 (en) 2006-07-29 2014-10-22 i-Sens, Inc. Electrochemical determination system of glycated proteins
JP4437216B2 (ja) * 2007-01-30 2010-03-24 アークレイ株式会社 フェノチアジン誘導体色素の検出方法およびそれに用いる発色剤試薬
US8574913B2 (en) 2007-10-30 2013-11-05 Panasonic Corporation Method for measurement of hemoglobin and hemoglobin derivative, and measurement kit
CN101493467A (zh) * 2008-01-25 2009-07-29 上海伊思柏生物科技有限公司 定量测定糖化蛋白质的方法
KR101005559B1 (ko) * 2008-07-15 2011-01-05 주식회사 아이센스 바이오센서를 이용한 단백질 측정 장치
WO2010009459A1 (en) * 2008-07-18 2010-01-21 Bayer Healthcare Llc Methods, devices, and systems for glycated hemoglobin analysis
JP5574977B2 (ja) 2008-12-11 2014-08-20 積水メディカル株式会社 糖化ヘモグロビン含有試料の前処理法
US20100167306A1 (en) * 2008-12-26 2010-07-01 Henry John Smith Rapid test for glycated albumin in saliva
EP2433140B1 (en) * 2009-05-20 2015-02-11 Relia Diagnostic Systems, Inc. Systems and methods for determining the percentage of glycated hemoglobin
KR101810264B1 (ko) * 2010-03-31 2017-12-18 세키스이 메디칼 가부시키가이샤 헤모글로빈류의 분석 방법
JP5906604B2 (ja) * 2011-08-11 2016-04-20 東洋紡株式会社 全血検体の成分測定方法
KR101207418B1 (ko) 2012-02-10 2012-12-04 주식회사 아이센스 효소법을 이용하는 당화혈색소 정량분석용 용혈시약 조성물
CN106461682B (zh) 2014-05-06 2018-09-21 德赛诊断系统有限公司 HbA1c的酶促测定
CN104062430B (zh) * 2014-06-30 2016-03-30 洛阳普莱柯万泰生物技术有限公司 一种用于检测样品中流感病毒的试剂盒及其检测方法和应用
WO2017114893A1 (en) * 2015-12-30 2017-07-06 Peter Warthoe Method for determining the quantity of an hba1c in a blood sample
WO2020054572A1 (ja) * 2018-09-12 2020-03-19 積水メディカル株式会社 ヘモグロビン類測定用試薬及びヘモグロビン類の測定方法
CN110702894A (zh) * 2019-10-10 2020-01-17 南京欧凯生物科技有限公司 一种直接测定糖化血红蛋白含量的检测方法
WO2021202685A1 (en) * 2020-03-31 2021-10-07 Somnio Global Holdings, Llc Device and methods for rapid detection of target analytes in a biological sample
CN112067566A (zh) * 2020-08-28 2020-12-11 南开大学 一种用于糖化血红蛋白定量分析的比色传感器
CN114441750B (zh) * 2020-10-30 2025-03-28 深圳市瑞图生物技术有限公司 用于全血样本免疫五项测定的试剂、试剂盒、方法和装置
CN113984689B (zh) * 2021-10-25 2023-11-03 中元汇吉生物技术股份有限公司 一种测定谷胱甘肽还原酶的试剂盒

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247533A (en) * 1978-05-01 1981-01-27 The Rockefeller University Hemoglobin A1c radioimmunoassay
US4200435A (en) * 1978-12-26 1980-04-29 Abbott Laboratories Determination of glycosylated hemoglobin in blood
JPS5861465A (ja) * 1981-10-07 1983-04-12 Mitsubishi Chem Ind Ltd 血液の分析方法
US4478744A (en) * 1982-01-25 1984-10-23 Sherwood Medical Company Method of obtaining antibodies
HU186976B (en) * 1982-10-01 1985-10-28 Reanal Finomvegyszergyar Process for determation of glucose containt of glucolized in non-ensimatic way proteins and reagent lutes for this process
US4529705A (en) * 1983-06-06 1985-07-16 Coulter Electronics, Inc. Reagent for combined diluting and lysing whole blood
US4727036A (en) * 1985-08-08 1988-02-23 Molecular Diagnostics, Inc. Antibodies for use in determining hemoglobin A1c
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
CA1339952C (en) * 1984-10-29 1998-07-14 William J. Knowles Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto
US4647654A (en) * 1984-10-29 1987-03-03 Molecular Diagnostics, Inc. Peptides useful in preparing hemoglobin A1c immunogens
JPS61148369A (ja) * 1984-12-06 1986-07-07 テクニコン・インストウルメンツ・コーポレイシヨン シアニドを含まないヘモグロビン試薬
DK145385D0 (da) * 1985-03-29 1985-04-01 Novo Industri As Monoklonalt antistof til immunkemisk analyse
DE3532868A1 (de) * 1985-09-14 1987-03-26 Boehringer Mannheim Gmbh Verfahren und reagenz zur bestimmung von glykosiliertem haemoglobin sowie hierzu geeignete verbindungen und verfahren zu deren herstellung
US4806468A (en) * 1987-02-05 1989-02-21 Becton, Dickinson And Company Measurement of glycosylated hemoglobin by immunoassay
US4861728A (en) * 1987-07-24 1989-08-29 Becton, Dickinson And Company Immunoassay of glycosylated hemoglobin using a labeled boron reagent
DE3733084A1 (de) * 1987-09-30 1989-04-13 Boehringer Mannheim Gmbh Testtraeger zur analytischen bestimmung eines bestandteils einer koerperfluessigkeit
US4970171A (en) * 1987-11-09 1990-11-13 Miles Inc. Denaturant reagents for convenient determination of hemoglobin derivatives in blood
JP2619900B2 (ja) * 1988-01-27 1997-06-11 東亜医用電子株式会社 血液中の白血球およびヘモグロビンの測定用試薬および方法
NO890029D0 (no) * 1989-01-04 1989-01-04 Axis Research Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes).
IL94724A (en) * 1989-07-13 1994-02-27 Miles Inc Decomposition of red blood cells and denaturation of hemoglobin by the use of lithium salts
JP2836865B2 (ja) * 1989-10-23 1998-12-14 東亜医用電子株式会社 血液中の白血球およびヘモグロビンの測定用試薬
JP2891302B2 (ja) * 1990-03-01 1999-05-17 シスメックス株式会社 血液中の白血球およびヘモグロビンの測定用試薬
US5242832A (en) * 1990-03-01 1993-09-07 Toa Medical Electronics Co., Ltd. Reagent for measurement of leukocytes and hemoglobin in blood
DE69121456T2 (de) * 1990-05-09 1996-12-19 Hoffmann La Roche Stabilisiertes Harnsäurereagens
DE4135542A1 (de) * 1991-10-28 1993-04-29 Boehringer Mannheim Gmbh Lagerfaehige proteinloesungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0708337A3 (en) * 1994-10-19 1996-06-12 Fuji Photo Film Co Ltd Analytical element and analysis method for glycolysed hemoglobin
EP0779513A1 (en) 1995-12-14 1997-06-18 Fuji Photo Film Co., Ltd. Method for immunological determination of hemoglobin derivative and treating reagent for use therein

Also Published As

Publication number Publication date
EP0559164A2 (de) 1993-09-08
SK14993A3 (en) 1993-10-06
FI930975L (fi) 1993-09-06
US5541117A (en) 1996-07-30
IL104902A0 (en) 1993-07-08
PT559164E (pt) 2000-10-31
ZA931533B (en) 1994-09-04
CA2090981C (en) 1999-11-16
ATE193378T1 (de) 2000-06-15
SI9300108A (en) 1993-09-30
KR930020162A (ko) 1993-10-19
CZ29193A3 (en) 1994-01-19
PL297915A1 (en) 1993-09-06
FI930975A0 (fi) 1993-03-04
JP2637677B2 (ja) 1997-08-06
DE59310046D1 (de) 2000-06-29
EP0559164A3 (enExample) 1994-01-26
HRP930253A2 (en) 1995-10-31
JPH0611510A (ja) 1994-01-21
ES2148190T3 (es) 2000-10-16
NO930770L (no) 1993-09-06
NZ247054A (en) 1995-02-24
AU652092B2 (en) 1994-08-11
NO930770D0 (no) 1993-03-03
HUT70463A (en) 1995-10-30
FI930975A7 (fi) 1993-09-06
EP0559164B1 (de) 2000-05-24
DK0559164T3 (da) 2000-10-30
AU3387193A (en) 1993-09-16
CN1081765A (zh) 1994-02-09
CA2090981A1 (en) 1993-09-06
HU9300596D0 (en) 1993-05-28

Similar Documents

Publication Publication Date Title
DE4206932A1 (de) Immunologische methode zur bestimmung eines haemoglobinderivates
Schade et al. Bound iron and unsaturated iron-binding capacity of serum; rapid and reliable quantitative determination
US20090220936A1 (en) Flow Cytometry Reagent System
DE69119410T2 (de) Reagenz und verfahren zur kalziumbestimmung
DD203778A5 (de) Verfahren und reagens zur bestimmung von glykolisiertem haemoglobin
EP0064758B1 (de) Verfahren zur Bestimmung des Gehalts an glykosiliertem Hämoglobin bei der Langzeitkontrolle des Blutzuckerspiegels
DE69108439T2 (de) Verfahren zur Bestimmung des Glykationsprozentsatzes eines bestimmten Proteins.
CH632092A5 (de) Verfahren und mittel zur bestimmung von hydroperoxiden.
DE69625581T2 (de) Cyanidfreies Reagenz und Verfahren zur Bestimmung von Hämoglobin und Leukozytendifferenzierung
EP0003340A2 (de) Verfahren und Reagenz zur Bestimmung des Hämoglobingehaltes des Blutes
DE69617374T2 (de) Verfahren zum immunologischen Nachweis eines Hämoglobinderivates und Behandlungsreagenz zur Verwendung darin
DE3732688A1 (de) Verfahren zur spezifischen bestimmung des serumfructosamingehalts sowie hierfuer geeignetes reagenzgemisch
DE3311458C2 (de) Verfahren zur Herstellung einer glukosefreien Hämoglobinkontrolle
EP0664454A2 (de) Verfahren und Reagenz zur Bestimmung von Eisen
DE3314308A1 (de) Verfahren und reagens zur bestimmung des haemoglobin-haptoglobin komplexes in gegenwart von freiem haemoglobin
DE3920364C2 (enExample)
EP0874994B1 (de) Bestimmung der endständigen sialinsäurereste des human-transferrin-moleküls
US6194218B1 (en) Blood methemoglobin analysis
DE69812966T2 (de) Vorgefärbte 3,3',5,5'-tetramethylbenzidin-substrate zum nachweis von enzymaktivität
EP1119641B1 (de) Verfahren zur bestimmung von alkalischer phosphatase unter beseitigung von hämoglobin-störungen
EP0337467B1 (de) Verfahren zur Bestimmung von Thyroxin und dazu geeignete Standardlösung
DE19739120A1 (de) Verfahren zur Bestimmung der Antioxidanzkapazität von Proben
DE3546014A1 (de) Verfahren zur bestimmung der bindungskapazitaet des thyroxin bindenden tbg
EP0351790A2 (de) Verfahren zur Bestimmung von Fructosamin
DE4227102C2 (de) Immunchemisches Verfahren zum Nachweis eines Analyten

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE

8141 Disposal/no request for examination